[go: up one dir, main page]

DK1186298T3 - Indretninger og fremgangsmåder til indgivelse af cannabis til patienter - Google Patents

Indretninger og fremgangsmåder til indgivelse af cannabis til patienter

Info

Publication number
DK1186298T3
DK1186298T3 DK01307509T DK01307509T DK1186298T3 DK 1186298 T3 DK1186298 T3 DK 1186298T3 DK 01307509 T DK01307509 T DK 01307509T DK 01307509 T DK01307509 T DK 01307509T DK 1186298 T3 DK1186298 T3 DK 1186298T3
Authority
DK
Denmark
Prior art keywords
cannabis
cavity
chemical
backing layer
skin
Prior art date
Application number
DK01307509T
Other languages
English (en)
Inventor
Cal Cedric Herrmann
Su Ii Yum
Lawrence Lea Brooke
Original Assignee
Patch Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patch Tech Inc filed Critical Patch Tech Inc
Application granted granted Critical
Publication of DK1186298T3 publication Critical patent/DK1186298T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01307509T 2000-09-05 2001-09-04 Indretninger og fremgangsmåder til indgivelse af cannabis til patienter DK1186298T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/655,634 US6328992B1 (en) 1997-03-03 2000-09-05 Cannabinoid patch and method for cannabis transdermal delivery

Publications (1)

Publication Number Publication Date
DK1186298T3 true DK1186298T3 (da) 2006-05-08

Family

ID=24629717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01307509T DK1186298T3 (da) 2000-09-05 2001-09-04 Indretninger og fremgangsmåder til indgivelse af cannabis til patienter

Country Status (10)

Country Link
US (1) US6328992B1 (da)
EP (1) EP1186298B1 (da)
AT (1) ATE313320T1 (da)
AU (1) AU785275B2 (da)
CA (1) CA2356020C (da)
CY (1) CY1104990T1 (da)
DE (1) DE60116011T2 (da)
DK (1) DK1186298T3 (da)
ES (1) ES2253331T3 (da)
PT (1) PT1186298E (da)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
US20020111377A1 (en) * 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB0202385D0 (en) * 2002-02-01 2002-03-20 Gw Pharma Ltd Compositions for the treatment of nausea,vomiting,emesis,motion sicknes or like conditions
US8034843B2 (en) * 2002-02-01 2011-10-11 Gw Pharma Limited Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions
WO2003066130A2 (en) * 2002-02-07 2003-08-14 Massachusetts Institute Of Technology Transdermal drug delivery systems
IL148244A0 (en) * 2002-02-19 2002-09-12 Yissum Res Dev Co Anti-nausea and anti-vomiting activity of cannabidiol compounds
AU2003240824B9 (en) * 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
ES2471190T3 (es) * 2003-06-24 2014-06-25 Gw Pharma Limited Composiciones farmacéuticas que comprenden compuestos de tipo cannabicromeno
BRPI0416268A (pt) * 2003-11-05 2007-12-11 Unimed Pharmaceuticals Inc composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
TWI369203B (en) 2004-11-22 2012-08-01 Euro Celtique Sa Methods for purifying trans-(-)-△9-tetrahydrocannabinol and trans-(+)-△9-tetrahydrocannabinol
TWI366460B (en) 2005-06-16 2012-06-21 Euro Celtique Sa Cannabinoid active pharmaceutical ingredient for improved dosage forms
NZ601567A (en) 2005-09-29 2013-03-28 Albany Molecular Res Inc Process for production of delta-9-tetrahydrocannabinol
US20110150766A1 (en) * 2006-07-07 2011-06-23 Royds Robert B Transdermal patch with fatal overdose protection
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
CA2657332A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
DE102007006244B4 (de) * 2007-02-08 2012-03-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System zur Verabreichung wasserlöslicher Wirkstoffe
US11062795B2 (en) 2007-03-02 2021-07-13 Enigami Systems, Inc. Healthcare data system
JP5224163B2 (ja) * 2007-07-24 2013-07-03 コスメディ製薬株式会社 経皮吸収テープ製剤
EP2176208B1 (en) * 2007-07-30 2015-01-21 Zynerba Pharmaceuticals, Inc. Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
WO2010150245A1 (en) * 2009-06-24 2010-12-29 Tikun Olam Ltd. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts
US20110038915A1 (en) * 2009-08-14 2011-02-17 Eduardo Jose Gonzalez Chewing Gum Formula for Enhancing Psycho-Spirituality
US9155713B2 (en) * 2011-03-03 2015-10-13 Mark Stephen Saia Method and apparatus for alcohol administration and therapeutic treatments using same
US8758826B2 (en) 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
ES2851678T3 (es) 2014-07-21 2021-09-08 Glia Llc Método para el tratamiento de deterioro cognitivo o emocional asociado con la radioterapia y quimioterapia con cannabinoides
US11707556B2 (en) 2015-01-22 2023-07-25 Alps South, LLC Phase change material for thermal therapy and delivery of active ingredients
US9375417B2 (en) 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
US10028904B2 (en) 2014-12-04 2018-07-24 Wisconsin Alumni Research Foundation Transdermal cannabinoid formulations
EP3253368A4 (en) * 2015-02-02 2018-08-22 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
US9962340B2 (en) * 2015-06-09 2018-05-08 Life Tech Global, Llc Device and method for the transdermal delivery of cannabidiol
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
US10272125B2 (en) * 2015-09-14 2019-04-30 Life Tech Global, Llc Transdermal delivery of cannabidiol with other active moieties including cannabinoids
LT6486B (lt) 2016-04-13 2018-01-10 UAB "SatiMed" Aliejinio gelio kompozicija su aktyviausiais junginiais iš c. sativa ir m. arvensis ir jos pateikimo sistema, skirta giliųjų audinių uždegimo ir skausmo mažinimui
JP2019531163A (ja) 2016-07-21 2019-10-31 アルプス・サウス・リミテッド・ライアビリティ・カンパニーＡｌｐｓ Ｓｏｕｔｈ， ＬＬＣ 熱療法および活性物質の送達のための相転移物質
CA3046928A1 (en) 2016-12-16 2018-06-21 Sorrento Therapeutics, Inc. Fluid delivery apparatus having a gas extraction device and method of use
AU2017376502B2 (en) 2016-12-16 2023-10-05 Vivasor, Inc. Method for administering a medicament suitable for treating a migraine or cluster headache
US11344709B2 (en) 2016-12-16 2022-05-31 Sorrento Therapeutics, Inc. Fluid delivery apparatus having a controller assembly and method of use
US10603478B2 (en) 2016-12-16 2020-03-31 Sorrento Therapeutics, Inc. Fluid delivery apparatus and method of assembly
EP4023281A1 (en) * 2016-12-16 2022-07-06 Sorrento Therapeutics, Inc. Attachment band for a fluid delivery apparatus and method of use
CA3047307A1 (en) 2016-12-16 2018-06-21 Sorrento Therapeutics, Inc. Application device for a fluid delivery apparatus and method of use
WO2018125037A1 (en) * 2016-12-27 2018-07-05 John Garland Medical marijuana patch
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
CN110996926A (zh) 2017-07-20 2020-04-10 耶路撒冷希伯来大学伊萨姆研究开发有限公司 用于将亲脂性化合物递送进入和/或穿过皮肤的药物膜组合物
US20200188316A1 (en) * 2017-08-24 2020-06-18 Robert Bender Transdermal formulations suitable for administration of natural products comprising plant flour and an adhesive
US20190110981A1 (en) * 2017-10-17 2019-04-18 Life Tech Global, Llc Cannabinoid Patch
CN112739328B (zh) 2018-07-18 2024-03-08 戈拉特有限责任公司 大麻素的速释配方
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3113724A1 (en) * 2018-09-28 2020-04-02 Visceral Therapeutics Inc. Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions
JP7425072B2 (ja) * 2018-10-15 2024-01-30 アムノン・ヴァルディ 徐放性カンナビノイド及びその製品
US20220233464A1 (en) * 2019-05-17 2022-07-28 Future Foam, Inc. Cannabidiol infused foam element or surface
US11090346B2 (en) 2019-05-28 2021-08-17 Inbold Inc. Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery
MX2022002081A (es) * 2019-08-21 2022-03-11 Pure Green Pharmaceuticals Inc Aparato medico con cannabis sativa l.
CA3156257A1 (en) 2019-10-03 2021-04-08 Starton Therapeutics, Inc. TRANSDERMAL DELIVERY OF DRONABINOL
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
EP4041209A4 (en) 2019-10-11 2024-01-24 Pike Therapeutics, Inc. TRANSDERMAL COMPOSITIONS CONTAINING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF SEIZURE DISORDERS
WO2021074790A1 (en) 2019-10-14 2021-04-22 Pike Therapeutics, Inc., 1219014 B.C. Ltd. Transdermal delivery of cannabidiol
US20210177740A1 (en) * 2019-12-11 2021-06-17 Joel Studin Transpore delivery of cannabinoid and uses thereof
WO2021138710A1 (en) * 2020-01-09 2021-07-15 Sg Ventures Pty Limited Substrate for use in a transdermal patch or dressing
US20210236687A1 (en) * 2020-01-31 2021-08-05 Pac-Dent, Inc. Cannabinoid-based oral hemostatic compositions
MX2023000316A (es) * 2020-08-17 2023-02-22 Pike Therapeutics Inc Composiciones farmaceuticas y metodos para el tratamiento de la enfermedad de parkinson.
US20220087948A1 (en) * 2020-09-18 2022-03-24 Nanovibronix, Inc. Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment
MX2023006561A (es) * 2020-12-03 2023-07-06 Pike Therapeutics Inc Formulaciones farmaceuticas transdermicas que comprenden cbd o thc para el tratamiento del cancer.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US302116A (en) * 1884-07-15 Jean baptist alois db winteb
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery

Also Published As

Publication number Publication date
EP1186298B1 (en) 2005-12-21
CA2356020C (en) 2006-12-19
AU785275B2 (en) 2006-12-14
ES2253331T3 (es) 2006-06-01
PT1186298E (pt) 2006-05-31
DE60116011T2 (de) 2006-08-24
EP1186298A2 (en) 2002-03-13
CA2356020A1 (en) 2002-03-05
DE60116011D1 (de) 2006-01-26
ATE313320T1 (de) 2006-01-15
CY1104990T1 (el) 2009-11-04
US6328992B1 (en) 2001-12-11
EP1186298A3 (en) 2003-01-02
AU6554001A (en) 2002-03-07

Similar Documents

Publication Publication Date Title
DK1186298T3 (da) Indretninger og fremgangsmåder til indgivelse af cannabis til patienter
AU2961802A (en) Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system
DE50112720D1 (de) Transdermales therapeutisches system mit hochdispersem siliziumdioxid
PT91327A (pt) Emplastro de varias camadas
YU165789A (en) Use of asymmetrical membranes in agents for active substances controlled releasing
DE69524436D1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
CA2949821C (en) Self contained wound dressing with micropump
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
DK1524975T3 (da) Forbedret, transdermalt tilförselssystem til indgivelse af rotigotin
ATE526038T1 (de) Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
JP2006525316A5 (da)
ATE166574T1 (de) Pflaster zur transdermalen applikation mit einem wirkstoffhaltigem polymerfilm
DK722888A (da) Plaster med aktivstof til kontrolleret administration af aktivstoffer til huden
WO2002078602A3 (en) Transdermal delivery of pergolide
DK1251853T3 (da) Transdermalt terapeutisk system til indgivelse af zaleplon
ATE416738T1 (de) Schiene mit feuchtigkeitsundurchlässiger lage
JPS56100716A (en) Drug administration member
DE20221247U1 (de) Transdermal-Pflaster zum Verabreichen von Fentanyl
IT1170274B (it) Mezzi per la raccolta del sebo e per il relativo monitoraggio
JPH046165B2 (da)